Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
Cancer Chemother Rep
; 59(5): 989-94, 1975.
Article
en En
| MEDLINE
| ID: mdl-1106848
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Leucemia
/
Enfermedades del Sistema Nervioso Central
/
Ciclofosfamida
/
Mitolactol
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Risk_factors_studies
Límite:
Child
/
Humans
Idioma:
En
Revista:
Cancer Chemother Rep
Año:
1975
Tipo del documento:
Article